Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients With Type 1 Diabetes
Creatine monohydrate remains the gold standard and most extensively studied form, with the strongest evidence base for both efficacy and safety
NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy
HOW IT WORKS 1
Im not trying to create panic or, you know, thats the other thing I get accused of, is You are just saying these horrible things to get likes and clicks on social media. Im like, I am sounding the alarm because this is the path that society is happy for us to head down and Im not signing up for this. I deserve BB: I mean, youre not Like thats so funny that that would be an accusation
In a single piece, he concisely captures: the state of the field the most important clinical trials where the pipeline is headed These Clinical trials are raising the bar and expanding future treatment options: Retatrutide ~24% weight loss (triple agonist) MariTide 1216% weight loss (GLP-1 + GIP antagonist) CagriSema up to 20% weight loss + ~2% HbA1c drop Orforglipron oral GLP-1, HbA1c 1.5%, weight 7.6% IcoSema weekly semaglutide + once-weekly insulin Even more exciting
